THE DEFINITIVE GUIDE TO HEMGENIX

Number of eligible patients: CDEC mentioned the uncertainty in the quantity of people with reasonably critical to severe hemophilia B in Canada suitable for etranacogene dezaparvovec. Scientific experts consulted by CADTH indicated that some patients who are categorized as getting mild or average sickness can have a intense bleeding phenotype, whic